Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
My direct team is the best I have ever work with and my manager is one of the best in the industry
Qual é a melhor parte das suas compensações?
Restricted Stock Units and 401K match
O que você mais gosta nos lideres?
dedication to patients with cancer
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
dedication to patients with cancer
O que faz você mais feliz no trabalho?
new technology to treat cancer
Quais são algumas das melhores coisas da sua equipe?
collaborative, sense of urgency, courage to speak up, dedication to patients with cancer
Other Employee Reviews for Karyopharm Therapeutics
×